RUCONEST®

RUCONEST® (conestat alfa) is a recombinant human C1 esterase inhibitor (rhC1INH) indicated for treatment of acute angioedema attacks in adults, adolescents, and children (aged 2 years and above) with hereditary angioedema (HAE) due to C1 esterase inhibitor deficiency.

For more information select your country

RUCONEST® is present in more than 20 countries in Europe. If your country is not present on the map, please use the country contact details on the Contact page.
RUCONEST® is present in more than 20 countries in Europe. If your country is not present on the map, please use the country contact details on the Contact page.

RUC-INT-2020-0002 April 2020